维生素D调控T细胞在儿童重症肺炎发病中的作用研究进展
Research Progress on the Vitamin D in Regulating T Cells in the Pathogenesis of Severe Pneumonia in Children
DOI: 10.12677/ACM.2024.142637, PDF,    科研立项经费支持
作者: 郑艳兰, 赵 峰:衡阳市妇幼保健院,湖南 衡阳
关键词: 维生素DT细胞重症肺炎感染免疫Vitamin D T Cells Severe Pneumonia Infection Immune
摘要: 肺炎在发展中国家中是造成5岁以下儿童死亡和住院的最常见的原因,严重威胁儿童生命和健康。重症肺炎病情危重,进展迅速,易导致急性呼吸窘迫综合征、感染性休克、急性肾功能衰竭等并发症,对患者生命安全构成极大威胁。感染是儿童肺炎发生的最主要原因,病原体进入机体后,首先会激活固有免疫系统,当固有免疫无法清除入侵病原体时包括T细胞免疫在内的功能更强大的适应性免疫则会发挥效应。维生素D除了在骨稳态中的经典功能外,还在宿主防御、炎症、免疫和上皮修复发挥重要作用。维生素D缺乏的儿童在患重症肺炎时属于高危组,这意味着补充维生素D可能对这些患者有益。而T细胞在适应性免疫应答当中占据核心地位,维生素D可作为一种免疫调节剂通过直接、间接方式调控T细胞参与重症肺炎的发生、发展。本文综述维生素D调控T淋巴在细胞儿童重症肺炎发生发展中的作用及最新进展。
Abstract: Pneumonia is the most common cause of death and hospitalization in children under 5 years of age in developing countries, posing a serious threat to children’s lives and health. Severe pneumonia is severe and progresses rapidly, easily leading to acute respiratory distress syndrome, septic shock, acute renal failure and other complications, posing a great threat to patients’ life safety. In addition to its classic function in bone homeostasis, vitamin D also plays an important role in host defense, inflammation, immunity, and epithelial repair. Children with vitamin D deficiency are in the high-risk group for severe pneumonia, meaning vitamin D supplements may benefit these patients. T cells play a central role in adaptive immune response, and vitamin D can directly and indirectly regulate T cells to participate in the occurrence and development of severe pneumonia as an im-mune modulator. This article reviews the role of vitamin D in regulating T lymphocytes in the de-velopment and progression of severe pneumonia in children.
文章引用:郑艳兰, 赵峰. 维生素D调控T细胞在儿童重症肺炎发病中的作用研究进展[J]. 临床医学进展, 2024, 14(2): 4586-4596. https://doi.org/10.12677/ACM.2024.142637

参考文献

[1] (2014) Revised WHO Classification and Treatment of Pneumonia in Children at Health Facilities: Evidence Summaries. WHO Guidelines Approved by the Guidelines Review Committee. Geneva.
[2] Leung, A.K.C., Wong, A.H.C. and Hon, K.L. (2018) Community-Acquired Pneumonia in Children. Recent Patents on Inflammation & Allergy Drug Dis-covery, 12, 136-144. [Google Scholar] [CrossRef
[3] Chen, K. and Kolls, J.K. (2013) T Cell-Mediated Host Immune Defenses in the Lung. Annual Review of Immunology, 31, 605-633. [Google Scholar] [CrossRef] [PubMed]
[4] Altare, F., Lammas, D., Revy, P., et al. (1998) In-herited Interleukin 12 Deficiency in a Child with Bacille Calmette-Guerin and Salmonella enteritidis Disseminated Infec-tion. Journal of Clinical Investigation, 102, 2035-2040. [Google Scholar] [CrossRef
[5] Raju, R., Peters, B.S. and Breen, R.A. (2012) Lung Infections in the HIV-Infected Adult. Current Opinion in Pulmonary Medicine, 18, 253-258. [Google Scholar] [CrossRef
[6] Van de Veerdonk, F.L. and Netea, M.G. (2010) T-Cell Subsets and Antifungal Host Defenses. Current Fungal Infection Reports, 4, 238-243. [Google Scholar] [CrossRef] [PubMed]
[7] Paats, M.S., Bergen, I.M., Hanselaar, W.E., et al. (2013) Local and Systemic Cytokine Profiles in Nonsevere and Severe Community-Acquired Pneumonia. European Respiratory Soci-ety, 41, 1378-1385. [Google Scholar] [CrossRef] [PubMed]
[8] Yunis, J., Short, K.R. and Yu, D. (2023) Severe Respiratory Vi-ral Infections: T-Cell Functions Diverging from Immunity to Inflammation. Trends in Microbiology, 31, 644-656. [Google Scholar] [CrossRef] [PubMed]
[9] Sette, A., Sidney, J. and Crotty, S. (2023) T Cell Responses to SARS-CoV-2. Annual Review of Immunology, 41, 343-373. [Google Scholar] [CrossRef] [PubMed]
[10] Tay, M.Z., Poh, C.M., Rénia, L., et al. (2020) The Trinity of COVID-19: Immunity, Inflammation and Intervention. Nature Reviews Immunology, 20, 363-374. [Google Scholar] [CrossRef] [PubMed]
[11] Merad, M. and Martin, J.C. (2020) Pathological Inflammation in Patients with COVID-19: A Key Role for Monocytes and Macrophages. Nature Reviews Immunology, 20, 355-362. [Google Scholar] [CrossRef] [PubMed]
[12] Jarczak, D. and Nierhaus, A. (2022) Cytokine Storm-Definition, Causes, and Implications. International Journal of Molecular Sciences, 23, Article 11740. [Google Scholar] [CrossRef] [PubMed]
[13] Fajgenbaum, D.C. and June, C.H. (2020) Cytokine Storm. The New England Journal of Medicine, 383, 2255-2273. [Google Scholar] [CrossRef
[14] Maucourant, C., Queiroz, G.A.N., Samri, A., et al. (2019) Zika Virus in the Eye of the Cytokine Storm. European Cytokine Network, 30, 74-81. [Google Scholar] [CrossRef] [PubMed]
[15] Chen, H., Wang, F., Zhang, P., et al. (2019) Management of Cytokine Release Syndrome Related to CAR-T Cell Therapy. Frontiers of Medicine, 13, 610-617. [Google Scholar] [CrossRef] [PubMed]
[16] Indalao, I.L., Sawabuchi, T., Takahashi, E., et al. (2017) IL-1beta Is a Key Cytokine That Induces Trypsin Upregulation in the Influenza Virus-Cytokine-Trypsin Cycle. Archives of Virol-ogy, 162, 201-211. [Google Scholar] [CrossRef] [PubMed]
[17] Huppert, L.A., Matthay, M.A. and Ware, L.B. (2019) Pathogene-sis of Acute Respiratory Distress Syndrome. Seminars in Respiratory and Critical Care Medicine, 40, 31-39. [Google Scholar] [CrossRef] [PubMed]
[18] Tracey, K.J., Lowry, S.F., Fahey 3rd, T.J., et al. (1987) Cachec-tin/Tumor Necrosis Factor Induces Lethal Shock and Stress Hormone Responses in the Dog. Surgery, Gynecology & Obstetrics, 164, 415-422.
[19] Medina, R., Socher, S.H., Han, J.H., et al. (1989) Interleukin-1, Endotoxin or Tumor Necrosis Factor/Cachectin Enhance the Level of Plasminogen Activator Inhibitor Messenger RNA in Bovine Aortic En-dothelial Cells. Thrombosis Research, 54, 41-52. [Google Scholar] [CrossRef] [PubMed]
[20] Afzal, S., Lange, P., Bojesen, S.E., et al. (2014) Plasma 25-Hydroxyvitamin D, Lung Function and Risk of Chronic Obstructive Pulmonary Disease. Thorax, 69, 24-31. [Google Scholar] [CrossRef] [PubMed]
[21] Rippel, C., South, M., Butt, W.W., et al. (2012) Vitamin D Status in Critically Ill Children. Intensive Care Medicine, 38, 2055-2062. [Google Scholar] [CrossRef] [PubMed]
[22] Parekh, D., Dancer, R.C., Lax, S., et al. (2013) Vitamin D to Pre-vent Acute Lung Injury Following Oesophagectomy (VINDALOO): Study Protocol for a Randomised Placebo Con-trolled Trial. Trials, 14, Article No. 100. [Google Scholar] [CrossRef] [PubMed]
[23] Hollams, E.M., Hart, P.H., Holt, B.J., et al. (2011) Vitamin D and Atopy and Asthma Phenotypes in Children: A Longitudinal Cohort Study. European Respiratory Society, 38, 1320-1327. [Google Scholar] [CrossRef] [PubMed]
[24] Wilkinson, R.J., Llewelyn, M., Toossi, Z., et al. (2000) Influence of Vitamin D Deficiency and Vitamin D Receptor Polymorphisms on Tuberculosis among Gujarati Asians in West Lon-don: A Case-Control Study. The Lancet, 355, 618-621. [Google Scholar] [CrossRef
[25] Persson, L.J., Aanerud, M., Hiemstra, P.S., et al. (2012) Chronic Obstructive Pulmonary Disease Is Associated with Low Levels of Vitamin D. PLOS ONE, 7, e38934. [Google Scholar] [CrossRef] [PubMed]
[26] Lu, D., Zhang, J., Ma, C., et al. (2018) Link between Commu-nity-Acquired Pneumonia and Vitamin D Levels in Older Patients. Zeitschrift für Gerontologie und Geriatrie, 51, 435-439. [Google Scholar] [CrossRef] [PubMed]
[27] De Pascale, G., Vallecoccia, M.S., Schiattarella, A., et al. (2016) Clinical and Microbiological Outcome in Septic Patients with Extremely Low 25-Hydroxyvitamin D Levels at Ini-tiation of Critical Care. Clinical Microbiology and Infection, 22, 456.E7-456.E13. [Google Scholar] [CrossRef] [PubMed]
[28] Hansdottir, S., Monick, M.M., Hinde, S.L., et al. (2008) Respirato-ry Epithelial Cells Convert Inactive Vitamin D to Its Active Form: Potential Effects on Host Defense. The Journal of Immunology, 181, 7090-7099. [Google Scholar] [CrossRef] [PubMed]
[29] Zisi, D., Challa, A. and Makis, A. (2019) The Association be-tween Vitamin D Status and Infectious Diseases of the Respiratory System in Infancy and Childhood. Hormones (Ath-ens), 18, 353-363. [Google Scholar] [CrossRef] [PubMed]
[30] Shi, Y.Y., Liu, T.J., Fu, J.H., et al. (2016) Vitamin D/VDR Sig-naling Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Maintaining the Integrity of the Pulmonary Epitheli-al Barrier. Molecular Medicine Reports, 13, 1186-1194. [Google Scholar] [CrossRef] [PubMed]
[31] Baeke, F., Takiishi, T., Korf, H., et al. (2010) Vitamin D: Modulator of the Immune System. Current Opinion in Pharmacology, 10, 482-496. [Google Scholar] [CrossRef] [PubMed]
[32] Berry, D.J., Hesketh, K., Power, C., et al. (2011) Vita-min D Status Has a Linear Association with Seasonal Infections and Lung Function in British Adults. British Journal of Nutrition, 106, 1433-1440. [Google Scholar] [CrossRef
[33] Jovanovich, A.J., Ginde, A.A., Holmen, J., et al. (2014) Vita-min D Level and Risk of Community-Acquired Pneumonia and Sepsis. Nutrients, 6, 2196-2205. [Google Scholar] [CrossRef] [PubMed]
[34] Fried, D.A., Rhyu, J., Odato, K., et al. (2016) Maternal and Cord Blood Vitamin D Status and Childhood Infection and Allergic Disease: A Systematic Review. Nutrition Reviews, 74, 387-410. [Google Scholar] [CrossRef] [PubMed]
[35] Monlezun, D.J., Bittner, E.A., Christopher, K.B., et al. (2015) Vitamin D Status and Acute Respiratory Infection: Cross Sectional Results from the United States National Health and Nutrition Examination Survey, 2001-2006. Nutrients, 7, 1933-1944. [Google Scholar] [CrossRef] [PubMed]
[36] Urashima, M., Segawa, T., Okazaki, M., et al. (2010) Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza A in Schoolchildren. The American Journal of Clinical Nutrition, 91, 1255-1260. [Google Scholar] [CrossRef] [PubMed]
[37] Nicolae, M., Mihai, C.M., Chisnoiu, T., et al. (2023) Immunomodu-latory Effects of Vitamin D in Respiratory Tract Infections and COVID-19 in Children. Nutrients, 15, Article 3430. [Google Scholar] [CrossRef] [PubMed]
[38] Manaseki-Holland, S., Qader, G., Isaq, Masher, M., et al. (2010) Effects of Vitamin D Supplementation to Children Diagnosed with Pneumonia in Kabul: A Randomised Controlled Trial. Tropi-cal Medicine & International Health, 15, 1148-1155. [Google Scholar] [CrossRef] [PubMed]
[39] Remmelts, H.H., Spoorenberg, S.M., Oosterheert, J.J., et al. (2013) The Role of Vitamin D Supplementation in the Risk of Developing Pneumonia: Three Independent Case-Control Studies. Thorax, 68, 990-996. [Google Scholar] [CrossRef] [PubMed]
[40] Choudhary, N. and Gupta, P. (2012) Vitamin D Supplementa-tion for Severe Pneumonia—A Randomized Controlled Trial. Indian Pediatrics, 49, 449-454. [Google Scholar] [CrossRef] [PubMed]
[41] Litonjua, A.A. (2013) Vitamin D and Corticosteroids in Asthma: Synergy, Interaction and Potential Therapeutic Effects. Expert Review of Respiratory Medicine, 7, 101-104. [Google Scholar] [CrossRef] [PubMed]
[42] Colotta, F., Jansson, B. and Bonelli, F. (2017) Modulation of Inflammatory and Immune Responses by Vitamin D. Journal of Autoimmunity, 85, 78-97. [Google Scholar] [CrossRef] [PubMed]
[43] Hossein-Nezhad, A. and Holick, M.F. (2012) Optimize Dietary In-take of Vitamin D: An Epigenetic Perspective. Current Opinion in Clinical Nutrition & Metabolic Care, 15, 567-579. [Google Scholar] [CrossRef
[44] Holick, M.F. (2007) Vitamin D Deficiency. The New Eng-land Journal of Medicine, 357, 266-281. [Google Scholar] [CrossRef
[45] Martens, P.J., Gysemans, C., Verstuyf, A., et al. (2020) Vitamin D’s Effect on Immune Function. Nutrients, 12, Article 1248. [Google Scholar] [CrossRef] [PubMed]
[46] Liu, P.T., Sten-ger, S., Li, H., et al. (2006) Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response. Science, 311, 1770-1773. [Google Scholar] [CrossRef] [PubMed]
[47] Abrams, G.D., Feldman, D. and Safran, M.R. (2018) Effects of Vitamin D on Skeletal Muscle and Athletic Performance. Journal of the American Academy of Orthopaedic Surgeons, 26, 278-285. [Google Scholar] [CrossRef
[48] Luo, W., Liu, L., Yang, L., et al. (2018) The Vitamin D Receptor Regulates miR-140-5p and Targets the MAPK Pathway in Bone Development. Metabolism, 85, 139-150. [Google Scholar] [CrossRef] [PubMed]
[49] Hossein-Nezhad, A. and Holick, M.F. (2013) Vitamin D for Health: A Global Perspective. Mayo Clinic Proceedings, 88, 720-755. [Google Scholar] [CrossRef] [PubMed]
[50] Unger, W.W., Laban, S., Kleijwegt, F.S., et al. (2009) Induction of Treg by Monocyte-Derived DC Modulated by Vitamin D3 or Dexamethasone: Differential Role for PD-L1. European Journal of Immunology, 39, 3147-3159. [Google Scholar] [CrossRef] [PubMed]
[51] Penna, G. and Adorini, L. (2000) 1α,25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activa-tion. The Journal of Immunology, 164, 2405-2411. [Google Scholar] [CrossRef] [PubMed]
[52] Van Halteren, A.G., Van Etten, E., De Jong, E.C., et al. (2002) Redirection of Human Autoreactive T-Cells upon Interaction with Den-dritic Cells Modulated by TX527, an Analog of 1,25 Dihydroxyvitamin D3. Diabetes, 51, 2119-2125. [Google Scholar] [CrossRef] [PubMed]
[53] Xu, H., Soruri, A., Gieseler, R.K., et al. (1993) 1,25-Dihydroxyvitamin D3 Exerts Opposing Effects to IL-4 on MHC Class-II Antigen Expression, Accessory Activity, and Phagocytosis of Human Monocytes. Scandinavian Journal of Immunology, 38, 535-540. [Google Scholar] [CrossRef] [PubMed]
[54] Yao, L., Shi, Y., Zhao, X., et al. (2017) Vitamin D At-tenuates Hyperoxia-Induced Lung Injury through Downregulation of Toll-Like Receptor 4. International Journal of Mo-lecular Medicine, 39, 1403-1408. [Google Scholar] [CrossRef] [PubMed]
[55] Chen, Y., Liu, W., Sun, T., et al. (2013) 1,25-Dihydroxyvitamin D Promotes Negative Feedback Regulation of TLR Signaling via Targeting MicroRNA-155-SOCS1 in Macrophages. The Journal of Immunology, 190, 3687-3695. [Google Scholar] [CrossRef] [PubMed]
[56] Liu, G., Zhang, L. and Zhao, Y. (2010) Modulation of Immune Responses through Direct Activation of Toll-Like Receptors to T Cells. Clinical and Experimental Immunology, 160, 168-175. [Google Scholar] [CrossRef] [PubMed]
[57] Provvedini, D.M., Tsoukas, C.D., Deftos, L.J., et al. (1983) 1,25-Dihydroxyvitamin D3 Receptors in Human Leukocytes. Science, 221, 1181-1183. [Google Scholar] [CrossRef] [PubMed]
[58] Tsoukas, C.D., Provvedini, D.M. and Manolagas, S.C. (1984) 1,25-Dihydroxyvitamin D3: A Novel Immunoregulatory Hormone. Science, 224, 1438-1440. [Google Scholar] [CrossRef] [PubMed]
[59] Khader, S.A., Guglani, L., Rangel-Moreno, J., et al. (2011) IL-23 Is Required for Long-Term Control of Mycobacterium Tuberculosis and B Cell Follicle Formation in the Infected Lung. The Journal of Immunology, 187, 5402-5407. [Google Scholar] [CrossRef] [PubMed]
[60] Deng, J.C., Tateda, K., Zeng, X., et al. (2001) Transient Transgenic Expression of Gamma Interferon Promotes Legionella pneumophila Clearance in Immunocompetent Hosts. Infection and Immunity, 69, 6382-6390. [Google Scholar] [CrossRef
[61] Lettinga, K.D., Weijer, S., Speelman, P., et al. (2003) Re-duced Interferon-Gamma Release in Patients Recovered from Legionnaires’ Disease. Thorax, 58, 63-67. [Google Scholar] [CrossRef] [PubMed]
[62] Guo, H., Santiago, F., Lambert, K., et al. (2011) T Cell-Mediated Pro-tection against Lethal 2009 Pandemic H1N1 Influenza Virus Infection in a Mouse Model. Journal of Virology, 85, 448-455. [Google Scholar] [CrossRef
[63] Sun, K., Ye, J., Perez, D.R., et al. (2011) Seasonal FluMist Vaccination Induces Cross-Reactive T Cell Immunity against H1N1 (2009) Influenza and Secondary Bacterial Infections. The Journal of Immunology, 186, 987-993. [Google Scholar] [CrossRef] [PubMed]
[64] Cautivo, K.M., Bueno, S.M., Cortes, C.M., et al. (2010) Efficient Lung Recruitment of Respiratory Syncytial Virus-Specific Th1 Cells Induced by Recombinant Bacillus Calmette-Guerin Promotes Virus Clearance and Protects from Infection. The Journal of Immunology, 185, 7633-7645. [Google Scholar] [CrossRef] [PubMed]
[65] Ripple, M.J., You, D., Honnegowda, S., et al. (2010) Immuno-modulation with IL-4R Alpha Antisense Oligonucleotide Prevents Respiratory Syncytial Virus-Mediated Pulmonary Disease. The Journal of Immunology, 185, 4804-4811. [Google Scholar] [CrossRef] [PubMed]
[66] Romani, L., Puccetti, P. and Bistoni, F. (1997) Interleukin-12 in Infectious Diseases. Clinical Microbiology Reviews, 10, 611-636. [Google Scholar] [CrossRef
[67] Chen, G.H., McDonald, R.A., Wells, J.C., et al. (2005) The Gamma Interferon Receptor Is Required for the Protective Pulmo-nary Inflammatory Response to Cryptococcus neoformans. Infection and Immunity, 73, 1788-1796. [Google Scholar] [CrossRef
[68] Cenci, E., Mencacci, A., Del Sero, G., et al. (1999) Interleu-kin-4 Causes Susceptibility to Invasive Pulmonary Aspergillosis through Suppression of Protective Type I Responses. The Journal of Infectious Diseases, 180, 1957-1968. [Google Scholar] [CrossRef] [PubMed]
[69] Palmer, M.T., Lee, Y.K., Maynard, C.L., et al. (2011) Lineage-Specific Effects of 1,25-Dihydroxyvitamin D3 on the Development of Effector CD4 T Cells. Journal of Biological Chemistry, 286, 997-1004. [Google Scholar] [CrossRef
[70] Boonstra, A., Barrat, F.J., Crain, C., et al. (2001) 1alpha, 25-Dihydroxyvitamin D3 Has a Direct Effect on Naive CD4+ T Cells to Enhance the Development of Th2 Cells. The Journal of Immunology, 167, 4974-4980. [Google Scholar] [CrossRef] [PubMed]
[71] Paats, M.S., Bergen, I.M., Hanselaar, W.E., et al. (2013) T Helper 17 Cells Are Involved in the Local and Systemic Inflammatory Response in Community-Acquired Pneumonia. Thorax, 68, 468-474. [Google Scholar] [CrossRef] [PubMed]
[72] Ye, P., Rodriguez, F.H., Kanaly, S., et al. (2001) Requirement of Interleukin 17 Receptor Signaling for Lung CXC Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host Defense. Journal of Experimental Medicine, 194, 519-527. [Google Scholar] [CrossRef] [PubMed]
[73] Happel, K.I., Dubin, P.J., Zheng, M., et al. (2005) Divergent Roles of IL-23 and IL-12 in Host Defense against Klebsiella pneumoniae. Journal of Experimental Medicine, 202, 761-769. [Google Scholar] [CrossRef] [PubMed]
[74] Wu, Q., Martin, R.J., Rino, J.G., et al. (2007) IL-23-Dependent IL-17 Production Is Essential in Neutrophil Recruitment and Activity in Mouse Lung Defense against Respiratory Mycoplasma pneumoniae Infection. Microbes and Infection, 9, 78-86. [Google Scholar] [CrossRef] [PubMed]
[75] Moffitt, K.L., Gierahn, T.M., Lu, Y.J., et al. (2011) TH17-Based Vaccine Design for Prevention of Streptococcus pneumoniae Colonization. Cell Host & Microbe, 9, 158-165. [Google Scholar] [CrossRef] [PubMed]
[76] Priebe, G.P., Walsh, R.L., Cederroth, T.A., et al. (2008) IL-17 Is a Critical Component of Vaccine-Induced Protection against Lung Infection by Lipopolysaccharide-Heterologous Strains of Pseudomonas aeruginosa. The Journal of Immunology, 181, 4965-4975. [Google Scholar] [CrossRef] [PubMed]
[77] Brown, D.M., Lee, S., Garcia-Hernandez Mde, L., et al. (2012) Multifunctional CD4 Cells Expressing Gamma Interferon and Perforin Mediate Protection against Lethal In-fluenza Virus Infection. Journal of Virology, 86, 6792-6803. [Google Scholar] [CrossRef
[78] Huang, W., Na, L., Fidel, P.L., et al. (2004) Requirement of Interleu-kin-17A for Systemic Anti-Candida albicans Host Defense in Mice. The Journal of Infectious Diseases, 190, 624-631. [Google Scholar] [CrossRef] [PubMed]
[79] Hardison, S.E., Wozniak, K.L., Kolls, J.K., et al. (2010) Interleukin-17 Is Not Required for Classical Macrophage Activation in a Pulmonary Mouse Model of Cryptococcus neoformans Infection. In-fection and Immunity, 78, 5341-5351. [Google Scholar] [CrossRef
[80] Mahon, B.D., Wittke, A., Weaver, V., et al. (2003) The Targets of Vit-amin D Depend on the Differentiation and Activation Status of CD4 Positive T Cells. Journal of Cellular Biochemistry, 89, 922-932. [Google Scholar] [CrossRef] [PubMed]
[81] Borgogni, E., Sarchielli, E., Sottili, M., et al. (2008) Elocalcitol Inhibits In-flammatory Responses in Human Thyroid Cells and T Cells. Endocrinology, 149, 3626-3634. [Google Scholar] [CrossRef] [PubMed]
[82] Staeva-Vieira, T.P. and Freedman, L.P. (2002) 1,25-Dihydroxyvitamin D3 Inhibits IFN-Gamma and IL-4 Levels During in Vitro Polarization of Primary Murine CD4+ T Cells. The Journal of Immunology, 168, 1181-1189. [Google Scholar] [CrossRef] [PubMed]
[83] Chen, F., Liu, Z., Wu, W., et al. (2012) An Essential Role for TH2-Type Responses in Limiting Acute Tissue Damage During Experimental Helminth Infection. Nature Medicine, 18, 260-266. [Google Scholar] [CrossRef] [PubMed]
[84] Marshall, D., Sealy, R., Sangster, M., et al. (1999) TH Cells Primed During Influenza Virus Infection Provide Help for Qualitatively Distinct Antibody Responses to Subsequent Immunization. The Journal of Immunology, 163, 4673-4682. [Google Scholar] [CrossRef
[85] Clements, M.L., Betts, R.F., Tierney, E.L., et al. (1986) Serum and Nasal Wash Antibodies Associated with Resistance to Experimental Challenge with Influenza a Wild-Type Virus. Journal of Clinical Microbiology, 24, 157-160. [Google Scholar] [CrossRef] [PubMed]
[86] Palladino, G., Mozdzanowska, K., Washko, G., et al. (1995) Virus-Neutralizing Antibodies of Immunoglobulin G (IgG) but Not of IgM or IgA Isotypes Can Cure Influenza Virus Pneumonia in SCID Mice. Journal of Virology, 69, 2075-2081. [Google Scholar] [CrossRef] [PubMed]
[87] Renegar, K.B., Small Jr., PA., Boykins, L.G., et al. (2004) Role of IgA versus IgG in the Control of Influenza Viral Infection in the Murine Respiratory Tract. The Journal of Im-munology, 173, 1978-1986. [Google Scholar] [CrossRef] [PubMed]
[88] Kling, H.M., Shipley, T.W., Patil, S.P., et al. (2010) Relation-ship of Pneumocystis jiroveci Humoral Immunity to Prevention of Colonization and Chronic Obstructive Pulmonary Disease in a Primate Model of HIV Infection. Infection and Immunity, 78, 4320-4330. [Google Scholar] [CrossRef
[89] Weber, S.E., Tian, H. and Pirofski, L.A. (2011) CD8+ Cells Enhance Resistance to Pulmonary Serotype 3 Streptococcus pneumoniae Infection in Mice. The Journal of Immunology, 186, 432-442. [Google Scholar] [CrossRef] [PubMed]
[90] Gohil, S.K., Heo, M., Schoenbaum, E.E., et al. (2012) CD8+ T Cells and Risk for Bacterial Pneumonia and All-Cause Mortality among HIV-Infected Women. Journal of Acquired Im-mune Deficiency Syndromes, 60, 191-198. [Google Scholar] [CrossRef
[91] Carvalho, A., De Luca, A., Bozza, S., et al. (2012) TLR3 Essentially Promotes Protective Class I-Restricted Memory CD8+ T-Cell Responses to Aspergillus fumigatus in Hema-topoietic Transplanted Patients. Blood, 119, 967-977. [Google Scholar] [CrossRef] [PubMed]
[92] McAllister, F., Steele, C., Zheng, M., et al. (2004) T Cytotox-ic-1 CD8+ T Cells Are Effector Cells against Pneumocystis in Mice. The Journal of Immunology, 172, 1132-1138. [Google Scholar] [CrossRef] [PubMed]
[93] Hamada, H., Garcia-Hernandez Mde, L., Reome, J.B., et al. (2009) Tc17, a Unique Subset of CD8 T Cells That Can Protect against Lethal Influenza Challenge. The Journal of Im-munology, 182, 3469-3481. [Google Scholar] [CrossRef] [PubMed]
[94] Peiris, J.S., Hui, K.P. and Yen, H.L. (2010) Host Response to In-fluenza Virus: Protection versus Immunopathology. Current Opinion in Immunology, 22, 475-481. [Google Scholar] [CrossRef] [PubMed]
[95] Meissner, N.N., Lund, F.E., Han, S., et al. (2005) CD8 T Cell-Mediated Lung Damage in Response to the Extracellular Pathogen Pneumocystis Is Dependent on MHC Class I Expression by Radiation-Resistant Lung Cells. The Journal of Immunology, 175, 8271-8279. [Google Scholar] [CrossRef] [PubMed]
[96] Lysandropoulos, A.P., Jaquiery, E., Jilek, S., et al. (2011) Vitamin D Has a Direct Immunomodulatory Effect on CD8+ T Cells of Patients with Early Multiple Sclerosis and Healthy Control Subjects. Journal of Neuroimmunology, 233, 240-244. [Google Scholar] [CrossRef] [PubMed]
[97] Chen, J., Bruce, D. and Cantorna, M.T. (2014) Vitamin D Re-ceptor Expression Controls Proliferation of Naive CD8+ T Cells and Development of CD8 Mediated Gastrointestinal In-flammation. BMC Immunology, 15, Article No. 6. [Google Scholar] [CrossRef] [PubMed]